Study for people diagnosed with cerebral venous thrombosis
Part of Brain & nervous system, Heart & circulation clinical trials.
This study is for people who have been diagnosed with cerebral venous thrombosis (a blood clot in the brain’s venous system) at specific hospitals. It looks back at cases from 2014 to 2023 to learn from real-world patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of cerebral venous thrombosis (CVT).
- Your CVT diagnosis was made between 2014 and 2023.
- Your diagnosis was recorded at one of the 13 participating primary hospitals.
- There are no listed other exclusion conditions for this study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people who have a blood clot in the brain’s venous drainage system. It aims to better understand this condition and may help improve how it is recognized and managed.
This study uses MRI scans to look at how the brain's waste-clearing system (glymphatic function) and white matter are affected in people with cerebral venous disorders (either narrowing or blood clots in the brain's veins). It aims to improve understanding of these conditions, which may lead to better treatments.
This study tests a procedure to remove blood clots from the large veins that drain blood from the brain (called venous sinuses). It aims to improve symptoms like severe headaches, vision problems, and other effects of this condition for patients who have had symptoms for less than 3 weeks.
This study compares two blood thinners (dabigatran and rivaroxaban) to see which works better for treating a blood clot in the brain's veins. You may be eligible if you have a new diagnosis of this type of stroke and can start treatment within 14 days.
This study looks at the blood clots removed from the brain during a procedure called thrombectomy. By studying them, researchers hope to learn more about how to treat strokes and what causes them, which could help improve care.
This study looks at people with cerebral venous thrombosis who were treated with blood thinners taken by mouth (or started within the first 30 days). It uses observational data to understand how these treatments are used and what outcomes may follow.
Hear when a new Cerebral Venous Sinus Thrombosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.